The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-006 study of pembrolizumab (pembro) versus ipilimumab (ipi) for advanced melanoma: Efficacy by PD-L1 expression and line of therapy.
 
Adil Daud
Stock and Other Ownership Interests - Oncosec
Consulting or Advisory Role - GlaxoSmithKline; Merck; Oncosec
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck/Schering Plough (Inst); oncosec (Inst); Pfizer (Inst)
 
Christian U. Blank
Stock and Other Ownership Interests - Verastem
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Research Funding - Novartis
Expert Testimony - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Novartis; Roche
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
 
Igor Puzanov
Consulting or Advisory Role - Amgen; Roche/Genentech
Travel, Accommodations, Expenses - Amgen
 
Erika Richtig
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
 
Kim Allyson Margolin
Honoraria - Bristol-Myers Squibb; Genentech/ROche
Consulting or Advisory Role - Amgen; Inanovate; Nektar; NeoStem; Oncosec; Prothena
Research Funding - Altor Bioscience; Bristol-Myers Squibb
 
Steven O'Day
Honoraria - Merck
Consulting or Advisory Role - Merck
Research Funding - Merck
 
Marta Nyakas
Consulting or Advisory Role - Merck Sharp & Dohme (Inst)
 
Jose Lutzky
Honoraria - Bristol-Myers Squibb; Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche
Research Funding - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Merck; Merck Serono; Millennium; Novartis; Onconova Therapeutics; Prometheus; Viralytics
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Prometheus
 
Ahmad A. Tarhini
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme
Research Funding - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Prometheus
 
Elaine McWhirter
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Roche
 
Christian Caglevic
Speakers' Bureau - Bayer; GlaxoSmithKline
Research Funding - Bayer; Boehringer Ingelheim; GlaxoSmithKline; Medivation; Merck Sharp & Dohme
Other Relationship - Boehringer Ingelheim
 
Peter Mohr
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
 
Michael Millward
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - AstraZeneca; Merck Sharp & Dohme
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Immunovaccine; Merck; Novartis
Expert Testimony - Merck
 
Honghong Zhou
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Kenneth Emancipator
Employment - Celgene (I); Merck
Stock and Other Ownership Interests - Bayer; Celgene (I); Johnson & Johnson (I); Merck
 
Scot Ebbinghaus
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Nageatte Ibrahim
Employment - Merck
Stock and Other Ownership Interests - GlaxoSmithKline; Merck
 
Georgina V. Long
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Provectus; Roche/Genentech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche/Genentech